Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: Doug Meetmer who wrote (287)	5/4/1998 10:39:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 717

Doug, What's with the price action today? Do you think it was a sympathy move with Entremed? I have absolutely no idea. Initially I was worried that PCYC would be weak because ENMD, according to the market, was going to put all the other cancer therapies out of business. I intended to switch some of my ENMD windfall (I fortunately sold all of my small stake at the open) into PCYC if it showed weakness, but it didn't. Not all the cancer stocks were strong - e.g., MRVT was down, although QLTIF was up some. Maybe there are good results/announcements coming, and when people saw how ENMD moved they figured they'd better get in to PCYC quickly. I'm holding long. Peter